EMJ GOLD: Pharma news, views and analysis

For our fifth and final GOLD Nugget of season 2, Helena looks back to one of our most popular episodes featuring Davidek Herron, Global Head of Digital at Roche. In these snippets, Davidek gives some great insights into what digital transformation means to him, drawing upon his time playing professional basketball in New York to illustrate his move into the pharma industry and some tips on learning from failure. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Davidek's full episode: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron Davidek Herron on digital transformation: https://www.emg-gold.com/post/davidek-herron-on-digital-transformation Bridging the digital health divide: https://www.emg-gold.com/post/bridging-the-digital-health-divide

In this GOLD nugget, Helena looks back at thoughts shared by Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma from our special International Women's Day episode. Aliya reflects on her time playing basketball in her youth and fighting for gender equality both on and off the court, some key role models in her life and the importance of listening to engage rather than to reply. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Aliya's full episode: https://www.emg-gold.com/post/podcast-international-womens-day-special Bayer in top spot for equality, diversity and inclusion: https://www.emg-gold.com/post/bayer-in-top-spot-for-equality-diversity-and-inclusion Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action

This GOLD Nugget episode sees Helena reflect on some of the insights offered by Laurence Woollard, haemophilia patient advocate and Founder and Director of On The Pulse Consultancy. In these clips, Laurence shares his personal experience of living with haemophilia and his journey into patient advocacy, the knowledge gap between the pharmaceutical industry and patients living with rare diseases and more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Laurence's full episode: https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus The progress and pain points of patient centricity: https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity The rare disease disparity: https://www.emg-gold.com/post/the-rare-disease-disparity BioMarin supports haemophilia documentary initiative https://www.emg-gold.com/post/biomarin-supports-haemophilia-documentary-initiative Roche renews haemophilia pledge https://www.emg-gold.com/post/roche-renews-haemophilia-pledge

For this week's GOLD nugget, Helena highlights not one but two of GOLD's previous guests from the world of Medical Affairs: Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson, and Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology, AstraZeneca. They explore the potential value that can come from collaborating with different industries and some tips for measuring the value of medical affairs – it's not one to be missed! If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Luca's full episode: https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls Luisa's full episode: https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing The Leap from Medicine to Medical Affairs: https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs

The GOLD Podcast may be on a break, but Helena is still here to provide you with some great insights – or GOLD Nuggets, if you will – from key opinion leaders in the pharmaceutical industry. In this special episode, she looks back at the very first episode of Season 2 which featured Judy Stewart, Senior Vice President and Head of US Vaccines at GSK. Helena considers some of the gold nuggets that Judy shared, including insights on both the vaccine industry and her approach to leadership. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Judy's full podcast episode: https://www.emg-gold.com/post/vaccines-leadership-and-blockchain Judy's Catalyst interview https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases GSK warns against routine vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency Haleon demerger completed by GSK https://www.emg-gold.com/post/haleon-demerger-completed-by-gsk

As Helena and Marc wrap up this season, they're joined by Mike Watson, Chief Executive Officer of Mevox – a company committed to bringing vaccine technology into the 21st century. Mike discusses the importance of developing new measles, mumps and rubella (MMR) vaccines, Mevox's success so far in achieving this ambition – reaching series B funding – and its future trajectory, how COVID-19 will impact the future of vaccine development, along with a whole host of other fascinating insights. As Helena's favourite interview of Season 2, it's not one to be missed! If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The return of the vaccines https://www.emg-gold.com/post/the-return-of-the-vaccines Routine vaccinations: road to recovery https://www.emg-gold.com/post/routine-vaccinations-road-to-recovery A heyday for mRNA https://www.emg-gold.com/post/a-heyday-for-mrna Moderna set to bring mRNA innovation to UK https://www.emg-gold.com/post/moderna-set-to-bring-mrna-innovation-to-uk GSK warns against vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency

This week, Claire Gillis, CEO, VMLY&R Health joins Helena and Marc on the airwaves to discuss the health and pharma highlights from the recent Cannes Lions International Festival, including the power of technology, how to spend smart on campaigns and her top moment from the festival this year. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Talking to Claire Gillis https://www.emg-gold.com/post/podcast-talking-to-claire-gillis Innovative tech, pharma supply chains and more https://www.emg-gold.com/post/podcast-innovative-tech-pharma-supply-chains-and-more Spoonful of technology https://www.emg-gold.com/post/spoonful-of-technology-5 Cardiovascular catalyst launched by Novartis https://www.emg-gold.com/post/cardiovascular-catalyst-launched-by-novartis

In an interview double bill, Helena and Marc are joined two fantastic guests from the worlds of pharma marketing and commercial affairs. Michele Manto, Chief Commercial Officer, Galapagos, shares his thoughts on the differences in leading a large pharma company and an agile biotech, amongst other exciting topics, while Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk, talks all things marketing with insights into developing campaigns. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech Time to turn to TikTok https://www.emg-gold.com/post/time-to-turn-to-tiktok Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change

In this episode, GOLD is joined by recent catalyst interviewee Claus Zieler, President of Established Markets, Astellas, who discusses crisis management, the importance of leaders in shaping company culture, the innovation he is most excited about, and much more. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: Claus Zieler on leadership https://www.emg-gold.com/post/claus-zieler-on-leadership Reverse mentoring: a how-to guide https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide Supporting patients in a war zone https://www.emg-gold.com/post/supporting-patients-in-a-war-zone The hard sell of cell and gene therapies https://www.emg-gold.com/post/the-hard-sell-of-cell-and-gene-therapies

In this week's episode, the GOLD team is joined by Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson. After first meeting Luca when he contributed to a GOLD article about the transition from medicine to medical affairs in 2021, we invited him to join us on the airwaves to delve further into his experience within the function, he discusses how the medical affairs function has evolved, the future of the MSL, his views on the metaverse and the power of cross-industry partnership. If you're interested in learning more about the topic areas discussed in this episode, check out the following content: The leap from medicine to medical affairs https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse Driving access to digital, gene therapies and rare disease education https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus The progress and pain points of patient centricity https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity